Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Aspa

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Clinical Chemistry and Laboratory Medicine|September 17, 2025
Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumoniaAmaia Artaraz, Ane Uranga, Ana Jódar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 21, 2024
The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancerJacobo Rogado, Fernando Pozo, Kevin Troule, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Drug-resistant pneumococcal pneumonia: clinical relevance and related factorsJavier Aspa, Olga Rajas, Felipe Rodríguez de Castro, et al.
Plos One|October 23, 2020
Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumoniaJosé María Galván-Román, Ángel Lancho-Sánchez, Sergio Luquero-Bueno, et al.
Cancers|June 24, 2022
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLCJacobo Rogado, Fernando Pozo, Kevin Troule, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 23, 2022
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancerJacobo Rogado, Fernando Pozo, Kevin Troulé, et al.
Archivos De Bronconeumologia|March 28, 2019
Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired PneumoniaJose Curbelo, Olga Rajas, Belén Arnalich, et al.
Chest|May 10, 2014
Tobacco smoking increases the risk for death from pneumococcal pneumoniaSalvador Bello, Rosario Menéndez, Torres Antoni, et al.
Reumatologia Clinica|January 30, 2019
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unitJosé María Alvaro-Gracia, Miguel Arredondo, Esteban Daudén, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2008
Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adultsM Isabel Garcia-Laorden, Jordi Sole-Violan, Felipe Rodriguez de Castro, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|September 17, 2025
Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumoniaAmaia Artaraz, Ane Uranga, Ana Jódar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 21, 2024
The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancerJacobo Rogado, Fernando Pozo, Kevin Troule, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Drug-resistant pneumococcal pneumonia: clinical relevance and related factorsJavier Aspa, Olga Rajas, Felipe Rodríguez de Castro, et al.
Plos One|October 23, 2020
Usefulness of circulating microRNAs miR-146a and miR-16-5p as prognostic biomarkers in community-acquired pneumoniaJosé María Galván-Román, Ángel Lancho-Sánchez, Sergio Luquero-Bueno, et al.
Cancers|June 24, 2022
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLCJacobo Rogado, Fernando Pozo, Kevin Troule, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 23, 2022
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancerJacobo Rogado, Fernando Pozo, Kevin Troulé, et al.
Archivos De Bronconeumologia|March 28, 2019
Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired PneumoniaJose Curbelo, Olga Rajas, Belén Arnalich, et al.
Chest|May 10, 2014
Tobacco smoking increases the risk for death from pneumococcal pneumoniaSalvador Bello, Rosario Menéndez, Torres Antoni, et al.
Reumatologia Clinica|January 30, 2019
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unitJosé María Alvaro-Gracia, Miguel Arredondo, Esteban Daudén, et al.
The Journal of Allergy and Clinical Immunology|June 28, 2008
Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adultsM Isabel Garcia-Laorden, Jordi Sole-Violan, Felipe Rodriguez de Castro, et al.
Pageof 4